Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Observational 2

Sponsor

Conditions

Disease 3Prostatic Neoplasms 2Hereditary Cancer 2Colorectal Neoplasms 2Sarcoma, Kaposi 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain 1Neoplasms 1Lung Neoplasms 1Gynecologic Cancer 1Genetic Diseases, Inborn 1Development of the Virtual Biopsy 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colonic Neoplasms 1Chronic Pain 1Castleman Disease 1Cancer Pain 1COVID-19 1Breast Neoplasms 1Brain Neoplasms 1Anus Neoplasms 1Adenoma 1

Interventions

Diagnostic Tests, Routine 2Longitudinal Studies 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hereditary Cancer × Diagnostic Tests, Routine × Clear all
NCT03067389 2019-01-15

Combined Breast Cancer Risk Study

Myriad Genetic Laboratories, Inc.

Completed
553 enrolled

Hereditary Cancer

NCT03081455 2017-08-08

Impact of a Process Intervention on Screening and Testing Outcomes for Common Hereditary Cancer Syndromes

Myriad Genetic Laboratories, Inc.

Completed
145 enrolled

Hereditary Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡